Opposing roles of p38α-mediated phosphorylation and PRMT1-mediated arginine methylation in driving TDP-43 proteinopathy

Mari Aikio(Tufts University), James Shorter(University of Pennsylvania), Stephen J. Moss(Tufts University), Edward M. Barbieri(University of Pennsylvania), John Dunlop(AstraZeneca (South Korea)), Bo Lim Lee(University of Pennsylvania), Bradley Class(National Institutes of Health), Ashmita Baral(Gladstone Institutes), Jenna N. Beyer(University of Pennsylvania), Ryan R. Cupo(University of Pennsylvania), Reuben Thomas(Gladstone Institutes), Christopher J. Donnelly(University of Pittsburgh), Alice F. Ford(University of Pennsylvania), Korrie L. Mack(University of Pennsylvania), Lauren E. Drake(University of Pennsylvania), Hana M. Odeh(University of Pennsylvania), Thomas A. Ollerhead(Tufts University), Nicholas J. Brandon(C4 Therapeutics (United States)), Mohd Altaf Najar(Yenepoya University), Steven Finkbeiner(Gladstone Institutes), George M. Burslem(University of Pennsylvania), Dean G. Brown(AstraZeneca (United States)), Stephanie Lam(Gladstone Institutes), Nicholas A. Castello(Gladstone Institutes), Julia Kaye(Gladstone Institutes), Jocelyn C. Mauna(University of Pittsburgh), Aaron D. Gitler(Chan Zuckerberg Initiative (United States)), Ashkan Javaherian(Gladstone Institutes), Úna Chan(Gladstone Institutes), Heike J. Wobst(Jnana Therapeutics (United States)), Yuan-Ta Lin(Massachusetts Institute of Technology), Joshua L. Smalley(Tufts University)
Cell Reports
February 19, 2025
Cited by 2


Related Papers